This trial is active, not recruiting.

Condition breast cancer
Sponsor Institut Bergonié
Start date January 1990
End date January 2015
Trial size 21439 participants
Trial identifier NCT02893761, IB BASE SEIN


A database of breast cancer patients was established at Institute Bergonié since the 90s , to assess patients' survival, assess practice, search for prognostic factors.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

Overall Survival
time frame: 5 years
Overall Survival
time frame: 10 years

Secondary Outcomes

Distant disease-free survival
time frame: 10 years

Eligibility Criteria

Female participants at least 18 years old.

Inclusion Criteria: - Breast cancer - Aged 18 years and over - First treatment at Bergonie Institute Exclusion Criteria:

Trial information was received from ClinicalTrials.gov and was last updated in September 2016.
Information provided to ClinicalTrials.gov by Institut Bergonié.